BioPharm International - May 2023

BioPharm International May 2023

Issue link: https://www.e-digitaleditions.com/i/1499694

Contents of this Issue

Navigation

Page 37 of 37

bench to commercial expertise in advanced therapeutics Comprehensive solutions. Advanced technologies. Better biologics. us + 1 888 SOLUTION (765-8846) eur 00800 8855 6178 biologics.catalent.com © 2023 Catalent, Inc. All rights reserved. aav & lentiviral vectors plasmid dna & mrna autologous & allogeneic cell therapy & ipsc integrated solutions from preclinical to commercial Catalent is your global CDMO partner offering full-scale integrated solutions that can bring your next transformative cell and gene therapies to patients. From raw material to finished product for plasmid DNA, iPSC, mRNA, viral vector, and cell therapies, leverage our technical expertise, scale-up experience, and state-of-the-art facilities.

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - May 2023 - BioPharm International May 2023